Meloxicam Solution for Injection 10 Mg/Ml in 1.5 Tender - 147492152

Procurement Summary

Country: Ukraine

Summary: Meloxicam Solution for Injection 10 Mg/Ml in 1.5 Ml; Potassium Asparaginate/Magnesium Asparaginate Solution for Injections of 5 Ml; Balsamic Liniment According to Vyshevsky, 40 G Each; Venlafaxine, Capsules/Tablets, 75...

Deadline: 20 Aug 2026

Posting Date: 19 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 147492152

Document Ref. No.: UA-2026-08-17-007144-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 665500

CPV Classification

33600000 - Pharmaceutical products
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33660000 - Medicinal products for the nervous system and sensory organs

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Meloxicam solution for injection 10 mg/ml in 1.5 ml; Potassium asparaginate/Magnesium asparaginate solution for injections of 5 ml; Balsamic liniment according to Vyshevsky, 40 g each; Venlafaxine, capsules/tablets, 75 mg each; Vinpocetine, concentrate for solution for infusion (solution for injections), 5 mg/ml, 2 ml each; Gidazepam tablets of 20 mg; Choline alfoscerate, capsules, 400 mg each; Theophylline in a combination solution for infusions 2 mg/0.3 mg/0.2 mg/ml in 100 ml; Diclofenac/lidocaine solution for injection 37.5 mg/10 mg per 2 ml; Diclofenac solution for injection 25 mg/ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Drotaverin tablets 40 mg; Pregabalin, capsules, 75 mg each; Captopril/hydrochlorothiazide, tablets, 50/25 mg each; Quetiapine, film-coated tablets, 100 mg each; Ketorolac solution for injections, 30 mg/ml, 1 ml each; Zuclopenthixol solution for injection 50 mg/ml in 1 ml; Validol tablets of 100 mg; Corglycon solution for injection, 0.6 mg/ml, 1 ml each; Rivaroxaban film-coated tablets, 20 mg each; Citicoline, solution for injection, 125 mg/ml, 4 ml each; Meloxicam 15 mg tablets; Memantine, tablets, 10 mg each; Vitamin B1/B6/B12, solution for injection, 50 mg/50 mg/0.5 mg/1 ml, 2 ml each; Nimesulide, granules (granulated powder) for oral suspension, 100 mg/2 g, 2 g each; Combinations (16 % glucose solution - 500 ml; 9% solution of amino acids with electrolytes - 500 ml; 20% lipid emulsion), emulsion for infusions, 1250 ml each; Papaverine, solution for injection, 20 mg/ml, 2 ml each; Pentoxifylline, solution for other... Type of purchase: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: N05BA, Classification according to INN: Mono, Release form: Tablets, Dose of active substance: 20 mg, Packaging type: Blister; Theophylline in combination solution for infusions 2 mg/03, mg/0.2 mg/ml for 100 ml; Diclofenac/lidocaine solution for injection 37.5 m...

Documents

 Tender Notice